Filters

Alan L Whone, Mihaela Boca, Matthias Luz, Max Woolley, Lucy Mooney, Sonali Dharia, Jack Broadfoot, David Cronin, Christian Schroers, Neil U Barua, Lara Longpre, C Lynn Barclay, Chris Boiko, Greg A Johnson, H Christian Fibiger, Rob Harrison, Owen Lewis, Gemma Pritchard, Mike Howell, Charlie Irving, David Johnson, Suk Kinch, Christopher Marshall, Andrew D Lawrence, Stephan Blinder, Vesna Sossi, A Jon Stoessl, Paul Skinner, Erich Mohr, Steven S Gill

Journal of Parkinson's disease 2020;9(2):301-313

Free Full Text

Abstract

Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's disease.

Guido Straten, Ralf Saur, Christoph Laske, Thomas Gasser, Peter Annas, Hans Basun, Thomas Leyhe

Current Alzheimer research 2012;8(8):853-9

Full Text

Abstract

Emerging therapies for Parkinson's disease: from bench to bedside.

F I Tarazi, Z T Sahli, M Wolny, S A Mousa

Pharmacology & therapeutics 2015;144(2):123-33

Full Text

Abstract

Prostaglandin E (PGE) is a testicular peritubular cell-derived factor involved in human testicular homeostasis.

Frank-Michael Köhn, J Ullrich Schwarzer, Harald Welter, Mónica Beatriz Frungieri, Artur Mayerhofer, Soledad Paola Rossi, Kim-Gwendolyn Dietrich, Verónica Rey-Ares

Molecular and cellular endocrinology 2019;473():217-224

Full Text

Abstract

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism.

Luc Rochette, Marianne Zeller, Yves Cottin, Catherine Vergely

Trends in endocrinology and metabolism: TEM 2021;32(11):875-889

Free Full Text

Abstract

Altered blood parameters in "major depression" patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study.

Beyza Nur Ozkan, Kubra Bozali, Muhammed Emin Boylu, Halil Aziz Velioglu, Selman Aktas, Ismet Kirpinar, Eray Metin Guler

Translational psychiatry 2024;14(1):264

Free Full Text

Abstract

Results: 1 – 15 / 22

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Glial Cell Line-Derived Neurotrophic Factor""[mesh_terms]

GDNF and addiction.

The Role of Promyelocytic Leukemia Zinc Finger (PLZF) and Glial-Derived Neurotrophic Factor Family Receptor Alpha 1 (GFRα1) in the Cryopreservation of Spermatogonia Stem Cells.

Neurotrophic Properties, Chemosensory Responses and Neurogenic Niche of the Human Carotid Body.

Is GAS1 a co-receptor for the GDNF family of ligands?

Modulating Effects of Zingiberaceae Phenolic Compounds on Neurotrophic Factors and Their Potential as Neuroprotectants in Brain Disorders and Age-Associated Neurodegenerative Disorders: A Review.

Glial cell activity in cardiovascular diseases and risk of acute myocardial infarction.

Emerging novel treatment strategies for diabetic eye diseases.

Conformational changes of GDNF-derived peptide induced by heparin, heparan sulfate, and sulfated hyaluronic acid - Analysis by circular dichroism spectroscopy and molecular dynamics simulation.

Glial cells as key elements in the pathophysiology and treatment of bipolar disorder.

Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.

Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's disease.

Emerging therapies for Parkinson's disease: from bench to bedside.

Prostaglandin E (PGE) is a testicular peritubular cell-derived factor involved in human testicular homeostasis.

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism.

Altered blood parameters in "major depression" patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study.

Results for

""Glial Cell Line-Derived Neurotrophic Factor""[mesh_terms]